For example, copy number amplification of S100A14, significantly correlated with the increased S100A14 mRNA expression, is present in 5.4 to 20.7% of primary breast cancer patients and in approximately 26.1% of metastatic breast cancer patients (50). Here, S100A14 is linked to breast cancer.